Skip to content
10-Q

Quarterly Report

ACTAVIA LIFE SCIENCES, INC.

0001213900-22-050001

← back to feed
Filed
Aug 22, 2022 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2022 · Aug 22, 2022 179.98M sh
Current Liabilities Q3 2022 · Jun 30, 2022 $1.86M
Current Liabilities Q3 2022 · Sep 30, 2021 $2.8M
Total Assets Q3 2022 · Jun 30, 2022 $71.87K
Total Assets Q3 2022 · Sep 30, 2021 $44.58K
Shares Diluted Q3 2022 · Jun 30, 2021 68.91M sh
Shares Diluted Q3 2022 · Jun 30, 2021 68.91M sh
Operating Cash Flow Q3 2022 · Jun 30, 2021 −$253.4K
Stockholders Equity Q3 2022 · Jun 30, 2021 −$2.92M
Stockholders Equity restated Q3 2022 · Mar 31, 2021 −$2.8M
Stockholders Equity Q3 2022 · Sep 30, 2020 −$2.67M
Eps Diluted Q3 2022 · Jun 30, 2021 $0.00
Eps Diluted Q3 2022 · Jun 30, 2021 −$0.01
Eps Basic Q3 2022 · Jun 30, 2021 $0.00
Eps Basic Q3 2022 · Jun 30, 2021 −$0.01
Sga Expense Q3 2022 · Jun 30, 2021 $64.57K
Sga Expense Q3 2022 · Jun 30, 2021 $268.4K
Rd Expense Q3 2022 · Jun 30, 2021 $44.74K
Net Income Q3 2022 · Jun 30, 2021 −$123.59K
Net Income Q3 2022 · Jun 30, 2021 −$561.81K
Operating Income Q3 2022 · Jun 30, 2021 −$64.57K
Operating Income Q3 2022 · Jun 30, 2021 −$313.14K